ABIVAX Société Anonyme Income Statement Analysis

Revenue, earnings, and profit margins in millions EUR

Scroll to see more
ABIVAX Société Anonyme income statement - Annual data in millions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue10.794.574.514.200.01
Cost of Revenue0.000.0050.7645.5233.78
Gross Profit10.794.57-50.76-45.52-33.77
Operating Expenses
Research & Development146.53103.1848.3047.780.00
Selling, General & Administrative38.9028.827.495.585.60
Operating Expenses172.98131.9551.2141.405.83
Operating Income-172.98-127.38-51.21-41.40-39.60
Other Income/Expense
Interest Income8.962.420.000.000.00
Interest Expense12.43-13.836.943.56-2.32
Other Income/Expense2.67-6.58-4.272.430.00
Income
Income Before Tax-176.24-147.74-60.74-42.45-40.13
Income Tax Expense0.000.000.000.00-2.58
Net Income-176.24-147.74-60.74-42.45-37.55
Net Income - Continuous Operations-176.24-147.74-60.74-42.450.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-162.71-126.67-53.32-38.59-39.53
EBIT-163.81-127.38-53.80-38.89-39.60
Depreciation & Amortization1.100.710.070.160.07
Earnings Per Share
Basic EPS-3.00-3.00-3.00-3.00-3.00
Diluted EPS-3.00-3.00-3.00-3.00-3.00
Basic Shares Outstanding63.3543.0719.0915.4614.33
Diluted Shares Outstanding63.3543.0719.0915.4614.33